Antiparasitic Agents

Abstract

This chapter discusses the mechanisms of action, pharmacology, clinical utility, and adverse effects of common first‐line antiparasitic therapies and newer drug alternatives. Agents discussed in detail include albendazole, mebendazole, praziquantel, ivermectin, diethylcarbamazine, nitazoxanide, antimalarials, and those used to treat gastrointestinal protozoal infections, leishmaniasis, and trypanosomiasis.